Coronavirus

Advisers to U.S. military initiate a study on the latest threat to national security

In Plandemic, the former chronic fatigue syndrome researcher makes countless unsubstantiated claims and accusations

Top virologist Peter Piot spent 1 week at a London hospital in April and has been recovering at home since

This Ph.D. student wonders when she’ll be able to graduate

On this week’s show: Researchers are scrambling to produce antibodies to treat and prevent COVID-19, and how to avoid increasing deforestation during a tree-planting campaign

Government continues to greenlight projects despite reduced oversight

Several African leaders have expressed an interest in a plant-based tonic developed in Madagascar

Changes to health and habits could add noise to studies of experimental treatments

Institutions struggle with—and differ on—the best way to restart science

Research teams hunt antiviral “neuts” in blood of recovered COVID-19 patients, tweak existing antibodies or design new ones

Hints that children don’t spread coronavirus efficiently prompt debate

But nation shows no sign of interest, so far

Past respiratory epidemics among chimpanzee and gorilla groups suggest COVID-19 could devastate them

Emails show agency reacted to unproven claims that pandemic started at Wuhan, China, lab

Drawing on past crises, psychologists launch studies—and offer solutions

Remdesivir sped recovery of patients by several days, although it’s “not a home run”